The Golden Start to a Deviation Investigation

How you respond in the first 24 hours after discovering a deviation can make the difference between a minor quality issue and a major compliance problem. This critical window-what I call “The Golden Day”-represents your best opportunity to capture accurate information, contain potential risks, and set the stage for a successful investigation. When managed effectively, this initial day creates the foundation for identifying true root causes and implementing effective corrective actions that protect product quality and patient safety.

Why the First 24 Hours Matter: The Evidence

The initial response to a deviation is crucial for both regulatory compliance and effective problem-solving. Industry practice and regulatory expectations align on the importance of quick, systematic responses to deviations.

  • Regulatory expectations explicitly state that deviation investigation and root cause determination should be completed in a timely manner, and industry expectations usually align on deviations being completed within 30 days of discovery.
  • In the landmark U.S. v. Barr Laboratories case, “the Court declared that all failure investigations must be performed promptly, within thirty business days of the problem’s occurrence”
  • Best practices recommend assembling a cross-functional team immediately after deviation discovery and conduct initial risk assessment within 24 hours”
  • Initial actions taken in the first day directly impact the quality and effectiveness of the entire investigation process

When you capitalize on this golden window, you’re working with fresh memories, intact evidence, and the highest chance of observing actual conditions that contributed to the deviation.

Identifying the Problem: Clarity from the Start

Clear, precise problem definition forms the foundation of any effective investigation. Vague or incomplete problem statements lead to misdirected investigations and ultimately, inadequate corrective actions.

  • Document using specific, factual language that describes what occurred versus what was expected
  • Include all relevant details such as procedure and equipment numbers, product names and lot numbers
  • Apply the 5W2H method (What, When, Where, Who, Why if known, How much is involved, and How it was discovered)
  • Avoid speculation about causes in the initial description
  • Remember that the description should incorporate relevant records and photographs of discovered defects.
5W2HTypical questionsContains
Who?Who are the people directly concerned with the problem? Who does this? Who should be involved but wasn’t? Was someone involved who shouldn’t be?User IDs, Roles and Departments
What?What happened?Action, steps, description
When?When did the problem occur?Times, dates, place In process
Where?Where did the problem occur?Location
Why is it important?Why did we do this? What are the requirements? What is the expected condition?Justification, reason
How?How did we discover. Where in the process was it?Method, process, procedure
How Many? How Much?How many things are involved? How often did the situation happen? How much did it impact?Number, frequency

The quality of your deviation documentation begins with this initial identification. As I’ve emphasized in previous posts, the investigation/deviation report should tell a story that can be easily understood by all parties well after the event and the investigation. This narrative begins with clear identification on day one.

ElementsProblem Statement
Is used to…Understand and target a problem. Providing a scope. Evaluate any risks. Make objective decisions
Answers the following… (5W2H)What? (problem that occurred);When? (timing of what occurred); Where? (location of what occurred); Who? (persons involved/observers); Why? (why it matters, not why it occurred); How Much/Many? (volume or count); How Often? (First/only occurrence or multiple)
Contains…Object (What was affected?); Defect (What went wrong?)
Provides direction for…Escalation(s); Investigation

Going to the GEMBA: Being Where the Action Is

GEMBA-the actual place where work happens-is a cornerstone concept in quality management. When a deviation occurs, there is no substitute for being physically present at the location.

  • Observe the actual conditions and environment firsthand
  • Notice details that might not be captured in written reports
  • Understand the workflow and context surrounding the deviation
  • Gather physical evidence before it’s lost or conditions change
  • Create the opportunity for meaningful conversations with operators

Human error occurs because we are human beings. The extent of our knowledge, training, and skill has little to do with the mistakes we make. We tire, our minds wander and lose concentration, and we must navigate complex processes while satisfying competing goals and priorities – compliance, schedule adherence, efficiency, etc.

Foremost to understanding human performance is knowing that people do what makes sense to them given the available cues, tools, and focus of their attention at the time. Simply put, people come to work to do a good job – if it made sense for them to do what they did, it will make sense to others given similar conditions. The following factors significantly shape human performance and should be the focus of any human error investigation:

Physical Environment
Environment, tools, procedures, process design
Organizational Culture
Just- or blame-culture, attitude towards error
Management and Supervision
Management of personnel, training, procedures
Stress Factors
Personal, circumstantial, organizational

We do not want to see or experience human error – but when we do, it’s imperative to view it as a valuable opportunity to improve the system or process. This mindset is the heart of effective human error prevention.

Conducting an Effective GEMBA Walk for Deviations

When conducting your GEMBA walk specifically for deviation investigation:

  • Arrive with a clear purpose and structured approach
  • Observe before asking questions
  • Document observations with photos when appropriate
  • Look for environmental factors that might not appear in reports
  • Pay attention to equipment configuration and conditions
  • Note how operators interact with the process or equipment

A deviation gemba is a cross-functional team meeting that is assembled where a potential deviation event occurred. Going to the gemba and “freezing the scene” as close as possible to the time the event occurred will yield valuable clues about the environment that existed at the time – and fresher memories will provide higher quality interviews. This gemba has specific objectives:

  • Obtain a common understanding of the event: what happened, when and where it happened, who observed it, who was involved – all the facts surrounding the event. Is it a deviation?
  • Clearly describe actions taken, or that need to be taken, to contain impact from the event: product quarantine, physical or mechanical interventions, management or regulatory notifications, etc.
  • Interview involved operators: ask open-ended questions, like how the event unfolded or was discovered, from their perspective, or how the event could have been prevented, in their opinion – insights from personnel experienced with the process can prove invaluable during an investigation.

Deviation GEMBA Tips

Typically there is time between when notification of a deviation gemba goes out and when the team is scheduled to assemble. It is important to come prepared to help facilitate an efficient gemba:

  • Assemble procedures and other relevant documents and records. This will make references easier during the gemba.
  • Keep your team on-track – the gemba should end with the team having a common understanding of the event, actions taken to contain impact, and the agreed-upon next steps of the investigation.

You will gain plenty of investigational leads from your observations and interviews at the gemba – which documents to review, which personnel to interview, which equipment history to inspect, and more. The gemba is such an invaluable experience that, for many minor events, root cause and CAPA can be determined fairly easily from information gathered solely at the gemba.

Informal Rubric for Conducting a Good Deviation GEMBA

  • Describe the timeliness of the team gathering at the gemba.
  • Were all required roles and experts present?
  • Was someone leading or facilitating the gemba?
  • Describe any interviews the team performed during the gemba.
  • Did the team get sidetracked or off-topic during the gemba
  • Was the team prepared with relevant documentation or information?
  • Did the team determine batch impact and any reportability requirements?
  • Did the team satisfy the objectives of the gemba?
  • What did the team do well?
  • What could the team improve upon?

Speaking with Operators: The Power of Cognitive Interviewing

Interviewing personnel who were present when the deviation occurred requires special techniques to elicit accurate, complete information. Traditional questioning often fails to capture critical details.

Cognitive interviewing, as I outlined in my previous post on “Interviewing,” was originally created for law enforcement and later adopted during accident investigations by the National Transportation Safety Board (NTSB). This approach is based on two key principles:

  • Witnesses need time and encouragement to recall information
  • Retrieval cues enhance memory recall

How to Apply Cognitive Interviewing in Deviation Investigations

  • Mental Reinstatement: Encourage the interviewee to mentally recreate the environment and people involved
  • In-Depth Reporting: Encourage the reporting of all the details, even if it is minor or not directly related
  • Multiple Perspectives: Ask the interviewee to recall the event from others’ points of view
  • Several Orders: Ask the interviewee to recount the timeline in different ways. Beginning to end, end to beginning

Most importantly, conduct these interviews at the actual location where the deviation occurred. A key part of this is that retrieval cues access memory. This is why doing the interview on the scene (or Gemba) is so effective.

ComponentWhat It Consists of
Mental ReinstatementEncourage the interviewee to mentally recreate the environment and people involved.
In-Depth ReportingEncourage the reporting of all the details.
Multiple PerspectivesAsk the interviewee to recall the event from others’ points of view.
Several OrdersAsk the interviewee to recount the timeline in different ways.
  • Approach the Interviewee Positively:
    • Ask for the interview.
    • State the purpose of the interview.
    • Tell interviewee why he/she was selected.
    • Avoid statements that imply blame.
    • Focus on the need to capture knowledge
    • Answer questions about the interview.
    • Acknowledge and respond to concerns.
    • Manage negative emotions.
  • Apply these Four Components:
    • Use mental reinstatement.
    • Report everything.
    • Change the perspective.
    • Change the order.
  • Apply these Two Principles:
    • Witnesses need time and encouragement to recall information.
    • Retrieval cues enhance memory recall.
  • Demonstrate these Skills:
    • Recreate the original context and had them walk you through process.
    • Tell the witness to actively generate information.
    • Adopt the witness’s perspective.
    • Listen actively, do not interrupt, and pause before asking follow-up questions.
    • Ask open-ended questions.
    • Encourage the witness to use imagery.
    • Perform interview at the Gemba.
    • Follow sequence of the four major components.
    • Bring support materials.
    • Establish a connection with the witness.
    • Do Not tell them how they made the mistake.

Initial Impact Assessment: Understanding the Scope

Within the first 24 hours, a preliminary impact assessment is essential for determining the scope of the deviation and the appropriate response.

  • Apply a risk-based approach to categorize the deviation as critical, major, or minor
  • Evaluate all potentially affected products, materials, or batches
  • Consider potential effects on critical quality attributes
  • Assess possible regulatory implications
  • Determine if released products may be affected

This impact assessment is also the initial risk assessment, which will help guide the level of effort put into the deviation.

Factors to Consider in Initial Risk Assessment

  • Patient safety implications
  • Product quality impact
  • Compliance with registered specifications
  • Potential for impact on other batches or products
  • Regulatory reporting requirements
  • Level of investigation required

This initial assessment will guide subsequent decisions about quarantine, notification requirements, and the depth of investigation needed. Remember, this is a preliminary assessment that will be refined as the investigation progresses.

Immediate Actions: Containing the Issue

Once you’ve identified the deviation and assessed its potential impact, immediate actions must be taken to contain the issue and prevent further risk.

  • Quarantine potentially affected products or materials to prevent their release or further use
  • Notify key stakeholders, including quality assurance, production supervision, and relevant department heads
  • Implement temporary corrective or containment measures
  • Document the deviation in your quality management system
  • Secure relevant evidence and documentation
  • Consider whether to stop related processes

Industry best practices emphasize that you should Report the deviation in real-time. Notify QA within 24 hours and hold the GEMBA. Remember that “if you don’t document it, it didn’t happen” – thorough documentation of both the deviation and your immediate response is essential.

Affected vs Related Batches

Not every Impact is the same, so it can be helpful to have two concepts: Affected and Related.

  • Affected Batch:  Product directly impacted by the event at the time of discovery, for instance, the batch being manufactured or tested when the deviation occurred.
  • Related Batch:  Product manufactured or tested under the same conditions or parameters using the process in which the deviation occurred and determined as part of the deviation investigation process to have no impact on product quality.

Setting Up for a Successful Full Investigation

The final step in the golden day is establishing the foundation for the comprehensive investigation that will follow.

  • Assemble a cross-functional investigation team with relevant expertise
  • Define clear roles and responsibilities for team members
  • Establish a timeline for the investigation (remembering the 30-day guideline)
  • Identify additional data or evidence that needs to be collected
  • Plan for any necessary testing or analysis
  • Schedule follow-up interviews or observations

In my post on handling deviations, I emphasized that you must perform a time-sensitive and thorough investigation within 30 days. The groundwork laid during the golden day will make this timeline achievable while maintaining investigation quality.

Planning for Root Cause Analysis

During this setup phase, you should also begin planning which root cause analysis tools might be most appropriate for your investigation. Select tools based on the event complexity and the number of potential root causes and when “human error” appears to be involved, prepare to dig deeper as this is rarely the true root cause

Identifying Phase of your Investigation

IfThen you are at
The problem is not understood. Boundaries have not been set. There could be more than one problemProblem Understanding
Data needs to be collected. There are questions about frequency or occurrence. You have not had interviewsData Collection
Data has been collected but not analyszedData Analysis
The root cause needs to be determined from the analyzed dataIdentify Root Cause
Root Cause Analysis Tools Chart body { font-family: Arial, sans-serif; line-height: 1.6; margin: 20px; } table { border-collapse: collapse; width: 100%; margin-bottom: 20px; } th, td { border: 1px solid ; padding: 8px 12px; vertical-align: top; } th { background-color: ; font-weight: bold; text-align: left; } tr:nth-child(even) { background-color: ; } .purpose-cell { font-weight: bold; } h1 { text-align: center; color: ; } ul { margin: 0; padding-left: 20px; }

Root Cause Analysis Tools Chart

Purpose Tool Description
Problem Understanding Process Map A picture of the separate steps of a process in sequential order, including:
  • materials or services entering or leaving the process (inputs and outputs)
  • decisions that must be made
  • people who become involved
  • time involved at each step, and/or
  • process measurements.
Critical Incident Technique (CIT) A process used for collecting direct observations of human behavior that
  • have critical significance, and
  • meet methodically defined criteria.
Comparative Analysis A technique that focuses a problem-solving team on a problem. It compares one or more elements of a problem or process to evaluate elements that are similar or different (e.g. comparing a standard process to a failing process).
Performance Matrix A tool that describes the participation by various roles in completing tasks or deliverables for a project or business process.
Note: It is especially useful in clarifying roles and responsibilities in cross-functional/departmental positions.
5W2H Analysis An approach that defines a problem and its underlying contributing factors by systematically asking questions related to who, what, when, where, why, how, and how much/often.
Data Collection Surveys A technique for gathering data from a targeted audience based on a standard set of criteria.
Check Sheets A technique to compile data or observations to detect and show trends/patterns.
Cognitive Interview An interview technique used by investigators to help the interviewee recall specific memories from a specific event.
KNOT Chart A data collection and classification tool to organize data based on what is
  • Known
  • Need to know
  • Opinion, and
  • Think we know.
Data Analysis Pareto Chart A technique that focuses efforts on problems offering the greatest potential for improvement.
Histogram A tool that
  • summarizes data collected over a period of time, and
  • graphically presents frequency distribution.
Scatter Chart A tool to study possible relationships between changes in two different sets of variables.
Run Chart A tool that captures study data for trends/patterns over time.
Affinity Diagram A technique for brainstorming and summarizing ideas into natural groupings to understand a problem.
Root Cause Analysis Interrelationship Digraphs A tool to identify, analyze, and classify cause and effect relationships among issues so that drivers become part of an effective solution.
Why-Why A technique that allows one to explore the cause-and-effect relationships of a particular problem by asking why; drilling down through the underlying contributing causes to identify root cause.
Is/Is Not A technique that guides the search for causes of a problem by isolating the who, what, when, where, and how of an event. It narrows the investigation to factors that have an impact and eliminates factors that do not have an impact. By comparing what the problem is with what the problem is not, we can see what is distinctive about a problem which leads to possible causes.
Structured Brainstorming A technique to identify, explore, and display the
  • factors within each root cause category that may be affecting the problem/issue, and/or
  • effect being studied through this structured idea-generating tool.
Cause and Effect Diagram (Ishikawa/Fishbone) A tool to display potential causes of an event based on root cause categories defined by structured brainstorming using this tool as a visual aid.
Causal Factor Charting A tool to
  • analyze human factors and behaviors that contribute to errors, and
  • identify behavior-influencing factors and gaps.
Other Tools Prioritization Matrix A tool to systematically compare choices through applying and weighting criteria.
Control Chart A tool to monitor process performance over time by studying its variation and source.
Process Capability A tool to determine whether a process is capable of meeting requirements or specifications.

Making the Most of Your Golden Day

The first 24 hours after discovering a deviation represent a unique opportunity that should not be wasted. By following the structured approach outlined in this post-identifying the problem clearly, going to the GEMBA, interviewing operators using cognitive techniques, conducting an initial impact assessment, taking immediate containment actions, and setting up for the full investigation-you maximize the value of this golden day.

Remember that excellent deviation management is directly linked to product quality, patient safety, and regulatory compliance. Each well-managed deviation is an opportunity to strengthen your quality system.

I encourage you to assess your current approach to the first 24 hours of deviation management. Are you capturing the full value of this golden day, or are you letting critical information slip away? Implement these strategies, train your team on proper deviation triage, and transform your deviation response from reactive to proactive.

Your deviation management effectiveness doesn’t begin when the investigation report is initiated-it begins the moment a deviation is discovered. Make that golden day count.

Quality Escalation Best Practices: Ensuring GxP Compliance and Patient Safety

Quality escalation is a critical process in maintaining the integrity of products, particularly in industries governed by Good Practices (GxP) such as pharmaceuticals and biotechnology. Effective escalation ensures that issues are addressed promptly, preventing potential risks to product quality and patient safety. This blog post will explore best practices for quality escalation, focusing on GxP compliance and the implications for regulatory notifications.

Understanding Quality Escalation

Quality escalation involves raising unresolved issues to higher management levels for timely resolution. This process is essential in environments where compliance with GxP regulations is mandatory. The primary goal is to ensure that products are manufactured, tested, and distributed in a manner that maintains their quality and safety.

This is a requirement across all the regulations, including clinical. ICH E6(r3) emphasizes the importance of effective monitoring and oversight to ensure that clinical trials are conducted in compliance with GCP and regulatory requirements. This includes identifying and addressing issues promptly.

Key Triggers for Escalation

Identifying triggers for escalation is crucial. Common triggers include:

  • Regulatory Compliance Issues: Non-compliance with regulatory requirements can lead to product quality issues and necessitate escalation.
  • Quality Control Failures: Failures in quality control processes, such as testing or inspection, can impact product safety and quality.
  • Data Integrity: Significant concerns and failures in quality of data.
  • Supply Chain Disruptions: Disruptions in the supply chain can affect the availability of critical components or materials, potentially impacting product quality.
  • Patient Safety Concerns: Any issues related to patient safety, such as adverse events or potential safety risks, should be escalated immediately.
Escalation CriteriaExamples of Quality Events for Escalation
Potential to adversely affect quality, safety, efficacy, performance or compliance of product (commercial or clinical)•Contamination (product, raw material, equipment, micro; environmental)
•Product defect/deviation from process parameters or specification (on file with agencies, e.g. CQAs and CPPs)
•Significant GMP deviations
•Incorrect/deficient labeling
•Product complaints (significant PC, trends in PCs)
•OOS/OOT (e.g.; stability)
Product counterfeiting, tampering, theft•Product counterfeiting, tampering, theft reportable to Health Authority (HA)
•Lost/stolen IMP
•Fraud or misconduct associated with counterfeiting, tampering, theft
•Potential to impact product supply (e.g.; removal, correction, recall)
Product shortage likely to disrupt patient care and/or reportable to HA•Disruption of product supply due to product quality events, natural disasters (business continuity disruption), OOS impact, capacity constraints
Potential to cause patient harm associated with a product quality event•Urgent Safety Measure, Serious Breach, Significant Product Compliant, Safety Signal that are determined associated with a product quality event
Significant GMP non-compliance/event•Non-compliance or non-conformance event with potential to impact product performance meeting specification, safety efficacy or regulatory requirements
Regulatory Compliance Event•Significant (critical, repeat) regulatory inspection findings; lack of commitment adherence
•Notification of directed/for cause inspection
•Notification of Health Authority correspondence indicating potential regulatory action

Best Practices for Quality Escalation

  1. Proactive Identification: Encourage a culture where team members proactively identify potential issues. Early detection can prevent minor problems from escalating into major crises.
  2. Clear Communication Channels: Establish clear communication channels and protocols for escalating issues. This ensures that the right people are informed promptly and can take appropriate action.
  3. Documentation and Tracking: Use a central repository to document and track issues. This helps in identifying trends, implementing corrective actions, and ensuring compliance with regulatory requirements.
  4. Collaborative Resolution: Foster collaboration between different departments and stakeholders to resolve issues efficiently. This includes involving quality assurance, quality control, and regulatory affairs teams as necessary.
  5. Regulatory Awareness: Be aware of regulatory requirements and ensure that all escalations are handled in a manner that complies with these regulations. This includes maintaining confidentiality when necessary and ensuring transparency with regulatory bodies.

GxP Impact and Regulatory Notifications

In industries governed by GxP, any significant quality issues may require notification to regulatory bodies. This includes situations where product quality or patient safety is compromised. Best practices for handling such scenarios include:

  • Prompt Notification: Notify regulatory bodies promptly if there is a risk to public health or if regulatory requirements are not met.
  • Comprehensive Reporting: Ensure that all reports to regulatory bodies are comprehensive, including details of the issue, actions taken, and corrective measures implemented.
  • Continuous Improvement: Use escalations as opportunities to improve processes and prevent future occurrences. This includes conducting root cause analyses and implementing preventive actions.

Fit with Quality Management Review

This fits within the Quality Management Review band, being an ad hoc triggered review of significant issues, ensuring appropriate leadership attention, and allowing key decisions to be made in a timely manner.

Conclusion

Quality escalation is a vital component of maintaining product quality and ensuring patient safety in GxP environments. By implementing best practices such as proactive issue identification, clear communication, and collaborative resolution, organizations can effectively manage risks and comply with regulatory requirements. Understanding when and how to escalate issues is crucial for preventing potential crises and ensuring that products meet the highest standards of quality and safety.

Terms Matter and Differentiate the GxPs

About once a year, I find the need to criticize the GAMP5 writing teams for their use of terms. Seriously, change the name already.

This year’s rant is triggered by reading a good practices guide designed to be pan-GxP and getting frustrated by its utter GMP focus. I knew I was in trouble when it specifically discussed “Product and Process Understanding” as a critical factor and then referenced ICH Q10. Use those terms with ICH Q10, and you just announced to the entire world that this is a GMP book. It is important to use a wider term and then reference product/process understanding as one subcategory or way of meeting it.

I rather like the approach of ICH E6 and E8 here, which is to use the wider term “Critical to Quality,” which in the broader sense can be expanded to mean the key factors that must be controlled or monitored to ensure the quality, safety, and efficacy of pharmaceutical products from development to clinical studies to manufacturing and distribution and beyond. It’s a risk-based approach focused on what matters most for patient safety and reliable results.